Internal Medicine, Cardiovascular Disease · Radford, VA
NPI
1104827088
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
401 E Main St
Radford, VA, 24141
Phone (540) 283-7252
Groups this clinician bills Medicare through
Medicare paid, 2024
$383K
5,917 services
Medicare patients, 2024
579
Average age 75
Drug cost, 2024
$2.5M
10,313 prescriptions
Company payments, 2025
$1,211
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sudhendu Choubey was code 99214 (office e&m - established), 1,529 times for 510 patients. In total Sudhendu Choubey billed 5,917 services in 34 codes, and Medicare paid $383K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,529 | 510 | $86.26 | $132K |
| 93000 Electrocardiogram | Office | 1,145 | 518 | $9.73 | $11K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 567 | 147 | $5.36 | $3,039 |
| 93306 Echocardiography (TTE/TEE) | Office | 363 | 337 | $125.41 | $46K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 338 | 167 | $83.74 | $28K |
| 93294 External Electrocardiographic Monitoring | Office | 297 | 118 | $20.36 | $6,048 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 292 | 281 | $127.59 | $37K |
| 93297 External Electrocardiographic Monitoring | Office | 210 | 30 | $17.05 | $3,580 |
| 93015 Electrocardiogram | Office | 173 | 171 | $46.84 | $8,103 |
| 78452 Myocardial Perfusion Scan | Office | 169 | 166 | $322.21 | $54K |
| 93970 Duplex Scan - Extremity Veins | Office | 149 | 141 | $136.31 | $20K |
| 93248 Electrocardiogram | Office | 119 | 116 | $18.78 | $2,235 |
| 93246 Electrocardiogram | Office | 90 | 88 | $8.72 | $784 |
| 93295 External Electrocardiographic Monitoring | Office | 82 | 37 | $26.56 | $2,178 |
| 99204 Office E&M - New | Office | 74 | 74 | $110.93 | $8,209 |
By year: 2022 $524K for 6,961 services; 2023 $451K for 6,527 services; 2024 $383K for 5,917 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sudhendu Choubey prescribed most often to Medicare patients was Metoprolol Succinate, with 1,626 prescriptions and refills. In total Sudhendu Choubey wrote 10,313 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,626 | 4,484 | 484 | $24K |
| Eliquis Apixaban | 575 | 1,002 | 135 | $565K |
| Losartan Potassium Generic | 560 | 1,560 | 173 | $4,881 |
| Rosuvastatin Calcium Generic | 540 | 1,463 | 168 | $6,504 |
| Xarelto Rivaroxaban | 414 | 746 | 83 | $413K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 411 | 1,109 | 130 | $3,907 |
| Midodrine Hcl Generic | 388 | 969 | 126 | $38K |
| Atorvastatin Calcium Generic | 387 | 1,062 | 116 | $2,641 |
| Amlodipine Besylate Generic | 383 | 1,082 | 133 | $1,496 |
| Furosemide Generic | 375 | 1,008 | 129 | $1,902 |
| Entresto Sacubitril/Valsartan | 324 | 585 | 78 | $383K |
| Ezetimibe Generic | 229 | 620 | 74 | $5,720 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 221 | 577 | 81 | $1,463 |
| Famotidine Generic | 157 | 385 | 48 | $1,747 |
| Spironolactone Generic | 154 | 435 | 49 | $986 |
Brand drugs: 2,206 claims; generic drugs: 8,107 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sudhendu Choubey $1,211 ($1,211 in general payments such as food, travel and fees) from 17 companies. The largest payer was United Therapeutics Corporation with $210.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 5 | $210 |
| Merck Sharp & Dohme LLC MRK | 11 | $198 |
| Novo Nordisk Inc NVO | 4 | $187 |
| Amgen Inc. AMGN | 6 | $105 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $84.39 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $76.45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49.59 |
| Inspire Medical Systems, Inc. INSP | 1 | $46.05 |
| Esperion Therapeutics, Inc. ESPR | 2 | $38.66 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $38.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.